These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15885352)

  • 1. MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices.
    Amitrano L; Guardascione MA; Bennato R; Manguso F; Balzano A
    J Hepatol; 2005 Jun; 42(6):820-5. PubMed ID: 15885352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the short- and long-term prognosis of patients with cirrhosis and acute variceal bleeding.
    Sempere L; Palazón JM; Sánchez-Payá J; Pascual S; de Madaria E; Poveda MJ; Carnicer F; Zapater P; Pérez-Mateo M
    Rev Esp Enferm Dig; 2009 Apr; 101(4):236-48. PubMed ID: 19492899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
    Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
    Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for end-stage liver disease (MELD) score for predicting late esophageal varices rebleeding in cirrhotic patients.
    Fong TV; Hung FC; Chiu KW; Chiu YC; Wu KL; Kuo CH; Kuo CM
    Hepatogastroenterology; 2008; 55(84):1055-8. PubMed ID: 18705327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma.
    Giannini EG; Risso D; Testa R; Trevisani F; Di Nolfo MA; Del Poggio P; Benvegnù L; Ludovico Rapaccini G; Farinati F; Zoli M; Borzio F; Caturelli E;
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1378-84. PubMed ID: 17059899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients.
    Hori S; Takaki A; Okada H; Fujiwara A; Takenaka R; Makidono C; Shiratori Y
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1704-9. PubMed ID: 16984593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH; Son JH; Kim TW
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH; Sheppard BC; Schwartz J; Orloff SL
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
    Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
    J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage.
    Hsu YC; Chung CS; Tseng CH; Lin TL; Liou JM; Wu MS; Hu FC; Wang HP
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1294-9. PubMed ID: 19682197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
    Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
    Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of predictive factors related to the mortality and rebleeding caused by variceal bleeding: Child-Pugh score, MELD score, and Rockall score].
    Lee JY; Lee JH; Kim SJ; Choi DR; Kim KH; Kim YB; Kim HY; Yoo JY
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):458-64. PubMed ID: 12506250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
    Mun BS; Ahn HS; Ahn DS; Lee SO
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding index after the first course of endoscopic treatment for esophageal varices in liver cirrhotic patients with and without hepatocellular carcinoma.
    Kogo M; Sato N; Yoneyama K; Imawari M; Kiuchi Y
    Hepatogastroenterology; 2007; 54(79):2049-54. PubMed ID: 18251158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.